Characterization of compounds on nicotinic acetylcholine receptor alpha7 channels using higher throughput electrophysiology

被引:23
|
作者
Friis, S. [1 ]
Mathes, C. [1 ]
Sunesen, M. [1 ]
Bowlby, M. R. [2 ]
Dunlop, J. [1 ]
机构
[1] Soph Biosc AS, Ballerup 2750, Denmark
[2] Wyeth Res, Princeton, NJ 08543 USA
关键词
Alpha7 nicotinic acetylcholine receptor; Automated patch clamp; QPatch; Ion channels; Acetylcholine; DRUG DISCOVERY; ALLOSTERIC MODULATOR; XENOPUS OOCYTES; BINDING-SITES; IN-VITRO; SCHIZOPHRENIA; AGONIST; INHIBITION; ACTIVATION; SUBTYPES;
D O I
10.1016/j.jneumeth.2008.10.007
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
Alpha7 nicotinic acetylcholine receptor channels are important ligand-gated ion channels that are fast desensitizing, cation selective and have been implicated in the pathophysiology of schizophrenia and Alzheimer's disease. We report here high quality alpha 7 parallel patch clamp recordings using the QPatch automated patch clamp system. The QPatch patch clamps up to 48 cells in parallel with the same high fidelity as conventional patch clamp. EC50 and IC50 values were comparable to values obtained with conventional patch clamp. The EC50 value for acetylcholine (ACh) on the QPatch with area under the curve (AUC) analysis was 26 mu M compared to a value of 29 mu M determined from conventional patch clamp experiments. Sequential additions of ACh can be made with minimal decay of the peak amplitude. The competitive alpha 7 antagonist methyllycaconitine (MLA) blocked currents with an IC50 value of 0.25 nM which is similar to published IC50 values for MLA. Finally, two different classes of positive allosteric modulators represented by PNU-120596 and NS-1738 elicited characteristic responses, thus allowing accurate characterization of modulation and measurements of potency. These results demonstrate that alpha 7 nicotinic acetylcholine receptor channels can be studied reliably in a higher throughput, parallel manner with the QPatch automated patch clamp system. (C) 2008 Elsevier B.V. All rights reserved.
引用
收藏
页码:142 / 148
页数:7
相关论文
共 50 条
  • [1] Silent agonists for alpha7 nicotinic acetylcholine receptor
    Chojnacka, Kinga
    Papke, Roger L.
    Horenstein, Nicole A.
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2013, 246
  • [2] Regulation of cytokine expression by acetylcholine and the alpha7 nicotinic receptor
    Waldburger, Jean-Marc
    Boyle, David L.
    Pavlov, Valentin A.
    Tracey, Kevin J.
    Firestein, Gary S.
    ARTHRITIS AND RHEUMATISM, 2008, 58 (09): : S186 - S186
  • [3] Alpha7 Nicotinic Acetylcholine Receptor Is a Target in Pharmacology and Toxicology
    Pohanka, Miroslav
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2012, 13 (02) : 2219 - 2238
  • [4] The alpha7 nicotinic acetylcholine receptor as a pharmacological target for inflammation
    de Jonge, W. J.
    Ulloa, L.
    BRITISH JOURNAL OF PHARMACOLOGY, 2007, 151 (07) : 915 - 929
  • [5] PROBING THE ROLE OF THE ALPHA7 NICOTINIC ACETYLCHOLINE RECEPTOR IN PSYCHOSIS
    Sawa, Akira
    SCHIZOPHRENIA BULLETIN, 2019, 45 : S125 - S125
  • [6] Alpha7 nicotinic acetylcholine receptor: A link between inflammation and neurodegeneration
    Conejero-Goldberg, Concepcion
    Davies, Peter
    Ulloa, Luis
    NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS, 2008, 32 (04): : 693 - 706
  • [7] Activation of the alpha7 nicotinic acetylcholine receptor improves skin fibrosis
    Stegemann, A.
    Boehm, M.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2019, 139 (09) : S323 - S323
  • [8] The Alpha7 nicotinic acetylcholine receptor is target for the treatment of skin fibrosis
    Boehm, M.
    Stegemann, A.
    BRAIN BEHAVIOR AND IMMUNITY, 2019, 81 : 49 - 50
  • [9] Targeting the nicotinic alpha7 acetylcholine receptor to enhance cognition in disease
    Wallace, Tanya L.
    Porter, Richard H. P.
    BIOCHEMICAL PHARMACOLOGY, 2011, 82 (08) : 891 - 903
  • [10] The alpha7 nicotinic acetylcholine receptor - a crucial modulator of cutaneous and extracutaneous fibrosis?
    Stegemann, A.
    Sindrilaru, A.
    Eckes, B.
    del Rey, A.
    Grando, S.
    Fiebich, B. L.
    Scharffetter-Kochanek, K.
    Luger, T. A.
    Boehm, M.
    EXPERIMENTAL DERMATOLOGY, 2018, 27 (03) : E28 - E28